Lv1
35 积分 2021-06-23 加入
Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T‐DM1) vs. treatment of physician's choice in previously treated HER2‐positive advanced breast cancer
2天前
已完结
Mastitis, Breast Abscess, and Granulomatous Mastitis
1个月前
已完结
Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
7个月前
已完结
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer
7个月前
已完结
Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta-Analysis
8个月前
已完结
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial
8个月前
已完结
The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer
8个月前
已关闭
THE CLINICAL AND BIOLOGICAL SIGNIFICANCE OF ESTROGEN RECEPTOR-LOW POSITIVE BREAST CANCER
8个月前
已完结
Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98
8个月前
已完结
Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
9个月前
已完结
皖公网安备34019202002308
